North America Human Milk Oligosaccharides Market Market Size, Share & Industry Analysis Report By Application (Infant Formula, Food & Beverages, Pharmaceuticals, and Dietary Supplements), By Type (2’FL, and LNnT), By Country Outlook and Forecast, 2026 - 2033

The North America Human Milk Oligosaccharides Market attained a market size of USD 133.8 million in 2025 and it is expected to reach USD 267.6 million by 2032, growing at a CAGR of 10.7% during 2026 - 2033.

The North America Human Milk Oligosaccharides (HMOs) Market originated from early scientific discoveries highlighting the importance of complex carbohydrates naturally present in human breast milk. Initially studied for their role in infant nutrition and immune development, HMOs gained commercial significance as advancements in glycomics, biotechnology, and microbial fermentation enabled large-scale production of key oligosaccharides such as 2’-Fucosyllactose (2’FL) and Lacto-N-neotetraose (LNnT).

The market is driven by rising awareness regarding infant nutrition, increasing adoption of premium infant formula products, growing interest in microbiome-focused healthcare, and continuous advancements in synthetic biology and fermentation technologies. Manufacturers are increasingly investing in HMO research, production capacity expansion, and innovative formulations that support digestive health, immune function, and overall wellness. Furthermore, growing regulatory acceptance and expanding clinical evidence continue to strengthen commercialization opportunities across North America.

Leading companies are focusing on biotechnology innovation, fermentation process optimization, portfolio expansion, and strategic partnerships with infant nutrition manufacturers and healthcare organizations. Investments in analytical technologies, production scalability, and regulatory compliance continue to enhance market competitiveness and support long-term growth.

Application Outlook

Based on Application, the North America Human Milk Oligosaccharides Market is segmented into Infant Formula, Dietary Supplements, Food & Beverages, and Pharmaceuticals.

The Infant Formula market dominated the North America Human Milk Oligosaccharides Market by Application in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 202.0 million by 2032, growing at a CAGR of 10.3 % during the forecast period. The Dietary Supplements market is expected to witness a CAGR of 11.2% during (2026 - 2033). Additionally, The Food & Beverages market is expected to witness highest CAGR of 12.1% during (2026 - 2033).

The Infant Formula segment garnered the highest revenue share in the market owing to increasing demand for advanced infant nutrition products that closely mimic the functional benefits of human breast milk. Dietary Supplements also recorded a significant share due to growing consumer focus on gut health, immunity, and microbiome support. Meanwhile, Food & Beverages and Pharmaceuticals continue to gain traction as manufacturers increasingly incorporate HMOs into functional nutrition products and microbiome-based therapeutic applications.

Type Outlook

Based on Type, the North America Human Milk Oligosaccharides Market is segmented into 2’FL, LNnT, 3’FL, 6’SL, 3’SL, LNT, and DFL. The 2’FL market dominated the North America Human Milk Oligosaccharides Market by Type in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 107.1 million by 2032, growing at a CAGR of 9.5 % during the forecast period. The LNnT market is expected to witness a CAGR of 9.7% during (2026 - 2033). Additionally, The 3’FL market is expected to witness highest CAGR of 11.3% during (2026 - 2033).

The 2’FL segment garnered the highest revenue share in the market owing to its extensive clinical validation, broad regulatory acceptance, and widespread use in infant nutrition products. LNnT also recorded a significant share due to increasing adoption in advanced infant formula formulations. Meanwhile, 3’FL, 6’SL, 3’SL, LNT, and DFL continue to witness growing demand as manufacturers seek to replicate the complexity and functional diversity of human breast milk.

Free Valuable Insights: The Global Human Milk Oligosaccharides Market will hit USD 891.2 Million billion by 2033, at a CAGR of 11.3%

Country Outlook

Based on Country, the North America Human Milk Oligosaccharides Market is segmented into the United States, Canada, Mexico, and Rest of North America. The US market dominated the North America Human Milk Oligosaccharides Market by Country in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 194.7 million by 2032, growing at a CAGR of 10 % during the forecast period.The Canada market is expected to witness a CAGR of 12.9% during (2026 - 2033).

The United States acquired a major share of the market owing to strong biotechnology capabilities, extensive infant nutrition research, and increasing adoption of HMO-enriched products. Canada also recorded a significant market share supported by regulatory approvals, growing consumer awareness, and expanding investments in advanced nutrition solutions. Meanwhile, Mexico and the Rest of North America are benefiting from increasing demand for premium infant formula products, rising healthcare awareness, and growing adoption of functional nutrition ingredients.

List of Key Companies Profiled

• DSM-Firmenich AG
• International Flavors & Fragrances Inc.
• BASF SE
• Abbott Laboratories
• Nestlé S.A.
• FrieslandCampina C.V.
• Novonesis A/S
• Inbiose NV
• KYOWA HAKKO BIO Co., Ltd. (Kirin Holdings Co., Ltd.)
• ELICITYL S.A.

North America Human Milk Oligosaccharides Market Report Segmentation

By Application

• Infant Formula
• Dietary Supplements
• Food & Beverages
• Pharmaceuticals

By Type

• 2’FL
• LNnT
• 3’FL
• 6’SL
• 3’SL
• LNT
• DFL

By Country

• United States
• Canada
• Mexico
• Rest of North America

Chapter 1. North America Market
1.1 Market Overview
1.2 Key Factors Impacting Market
1.2.1 Market Drivers
1.2.2 Market Restraints
1.2.3 Market Opportunities
1.2.4 Market Challenges
1.2.5 Market Trends
1.2.6 State of Competition
1.2.7 Market Consolidation
1.2.8 Key Customer Criteria
1.3 Product Life Cycle
1.4 Segmentation By Application
1.4.1 Infant Formula
1.4.2 Dietary Supplements
1.4.3 Food & Beverages
1.4.4 Pharmaceuticals
1.5 Segmentation By Type
1.5.1 ’FL
1.5.2 LNnT
1.5.3 ’FL
1.5.4 ’SL
1.5.5 ’SL
1.5.6 LNT
1.5.7 DFL
1.6 Segmentation By Country
1.6.1 US
1.6.1.1 Segmentation By Application
1.6.1.1.1 Infant Formula
1.6.1.1.2 Dietary Supplements
1.6.1.1.3 Food & Beverages
1.6.1.1.4 Pharmaceuticals
1.6.1.2 Segmentation By Type
1.6.1.2.1 ’FL
1.6.1.2.2 LNnT
1.6.1.2.3 ’FL
1.6.1.2.4 ’SL
1.6.1.2.5 ’SL
1.6.1.2.6 LNT
1.6.1.2.7 DFL
1.6.2 Canada
1.6.2.1 Segmentation By Application
1.6.2.1.1 Infant Formula
1.6.2.1.2 Dietary Supplements
1.6.2.1.3 Food & Beverages
1.6.2.1.4 Pharmaceuticals
1.6.2.2 Segmentation By Type
1.6.2.2.1 ’FL
1.6.2.2.2 LNnT
1.6.2.2.3 ’FL
1.6.2.2.4 ’SL
1.6.2.2.5 ’SL
1.6.2.2.6 LNT
1.6.2.2.7 DFL
1.6.3 Mexico
1.6.3.1 Segmentation By Application
1.6.3.1.1 Infant Formula
1.6.3.1.2 Dietary Supplements
1.6.3.1.3 Food & Beverages
1.6.3.1.4 Pharmaceuticals
1.6.3.2 Segmentation By Type
1.6.3.2.1 ’FL
1.6.3.2.2 LNnT
1.6.3.2.3 ’FL
1.6.3.2.4 ’SL
1.6.3.2.5 ’SL
1.6.3.2.6 LNT
1.6.3.2.7 DFL
1.6.4 Rest of North America
1.6.4.1 Segmentation By Application
1.6.4.1.1 Infant Formula
1.6.4.1.2 Dietary Supplements
1.6.4.1.3 Food & Beverages
1.6.4.1.4 Pharmaceuticals
1.6.4.2 Segmentation By Type
1.6.4.2.1 ’FL
1.6.4.2.2 LNnT
1.6.4.2.3 ’FL
1.6.4.2.4 ’SL
1.6.4.2.5 ’SL
1.6.4.2.6 LNT
1.6.4.2.7 DFL


Chapter 2. Company Snapshot
2.1 DSM-Firmenich AG
2.1.1 Business Overview
2.1.2 Key Information
2.1.3 Company Focus
2.1.4 Strategic Insights
2.1.5 Strategy Deployed
2.1.6 Product & Service Portfolio
2.1.7 Capability Overview
2.1.8 Technology & Innovation Focus
2.1.9 Customers / End Users
2.1.10 Competitive Positioning
2.1.11 Key Differentiators
2.1.12 Portfolio Matrix
2.1.13 SWOT Analysis
2.1.14 Future Outlook
2.2 Novozymes A/S
2.2.1 Business Overview
2.2.2 Key Information
2.2.3 Company Focus
2.2.4 Strategic Insights
2.2.5 Strategy Deployed
2.2.6 Product & Service Portfolio
2.2.7 Capability Overview
2.2.8 Technology & Innovation Focus
2.2.9 Customers / End Users
2.2.10 Competitive Positioning
2.2.11 Key Differentiators
2.2.12 Portfolio Matrix
2.2.13 SWOT Analysis
2.2.14 Future Outlook
2.3 International Flavors & Fragrances Inc.
2.3.1 Business Overview
2.3.2 Key Information
2.3.3 Company Focus
2.3.4 Strategic Insights
2.3.5 Strategy Deployed
2.3.6 Product & Service Portfolio
2.3.7 Capability Overview
2.3.8 Technology & Innovation Focus
2.3.9 Customers / End Users
2.3.10 Competitive Positioning
2.3.11 Key Differentiators
2.3.12 Portfolio Matrix
2.3.13 SWOT Analysis
2.3.14 Future Outlook
2.4 BASF SE
2.4.1 Business Overview
2.4.2 Key Information
2.4.3 Company Focus
2.4.4 Strategic Insights
2.4.5 Strategy Deployed
2.4.6 Product & Service Portfolio
2.4.7 Capability Overview
2.4.8 Technology & Innovation Focus
2.4.9 Customers / End Users
2.4.10 Competitive Positioning
2.4.11 Key Differentiators
2.4.12 Portfolio Matrix
2.4.13 SWOT Analysis
2.4.14 Future Outlook
2.5 Abbott Laboratories
2.5.1 Business Overview
2.5.2 Key Information
2.5.3 Company Focus
2.5.4 Strategic Insights
2.5.5 Strategy Deployed
2.5.6 Product & Service Portfolio
2.5.7 Capability Overview
2.5.8 Technology & Innovation Focus
2.5.9 Customers / End Users
2.5.10 Competitive Positioning
2.5.11 Key Differentiators
2.5.12 Portfolio Matrix
2.5.13 SWOT Analysis
2.5.14 Future Outlook
2.6 Nestlé S.A.
2.6.1 Business Overview
2.6.2 Key Information
2.6.3 Company Focus
2.6.4 Strategic Insights
2.6.5 Strategy Deployed
2.6.6 Product & Service Portfolio
2.6.7 Capability Overview
2.6.8 Technology & Innovation Focus
2.6.9 Customers / End Users
2.6.10 Competitive Positioning
2.6.11 Key Differentiators
2.6.12 Portfolio Matrix
2.6.13 SWOT Analysis
2.6.14 Future Outlook
2.7 FrieslandCampina C.V.
2.7.1 Business Overview
2.7.2 Key Information
2.7.3 Company Focus
2.7.4 Strategic Insights
2.7.5 Strategy Deployed
2.7.6 Product & Service Portfolio
2.7.7 Capability Overview
2.7.8 Technology & Innovation Focus
2.7.9 Customers / End Users
2.7.10 Competitive Positioning
2.7.11 Key Differentiators
2.7.12 Portfolio Matrix
2.7.13 SWOT Analysis
2.7.14 Future Outlook
2.8 KYOWA HAKKO BIO Co., Ltd.
2.8.1 Business Overview
2.8.2 Key Information
2.8.3 Company Focus
2.8.4 Strategic Insights
2.8.5 Strategy Deployed
2.8.6 Product & Service Portfolio
2.8.7 Capability Overview
2.8.8 Technology & Innovation Focus
2.8.9 Customers / End Users
2.8.10 Competitive Positioning
2.8.11 Key Differentiators
2.8.12 Portfolio Matrix
2.8.13 SWOT Analysis
2.8.14 Future Outlook
2.9 Inbiose NV
2.9.1 Business Overview
2.9.2 Key Information
2.9.3 Company Focus
2.9.4 Strategic Insights
2.9.5 Strategy Deployed
2.9.6 Product & Service Portfolio
2.9.7 Capability Overview
2.9.8 Technology & Innovation Focus
2.9.9 Customers / End Users
2.9.10 Competitive Positioning
2.9.11 Key Differentiators
2.9.12 Portfolio Matrix
2.9.13 SWOT Analysis
2.9.14 Future Outlook
2.10 ELICITYL S.A.
2.10.1 Business Overview
2.10.2 Key Information
2.10.3 Company Focus
2.10.4 Strategic Insights
2.10.5 Strategy Deployed
2.10.6 Product & Service Portfolio
2.10.7 Capability Overview
2.10.8 Technology & Innovation Focus
2.10.9 Customers / End Users
2.10.10 Competitive Positioning
2.10.11 Key Differentiators
2.10.12 Portfolio Matrix
2.10.13 SWOT Analysis
2.10.14 Future Outlook

List of Tables
TABLE 1 North America Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
TABLE 2 Methodology for the research
TABLE 3 Key Factors Impacting Market
TABLE 4 Market Consolidation
TABLE 5 Key Customer Criteria
TABLE 6 Product Life Cycle
TABLE 7 North America Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
TABLE 8 North America Dietary Supplements Market, 2022 - 2033, USD Million
TABLE 9 North America Food & Beverages Market, 2022 - 2033, USD Million
TABLE 10 North America Infant Formula Market, 2022 - 2033, USD Million
TABLE 11 North America Pharmaceuticals Market, 2022 - 2033, USD Million
TABLE 12 North America Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
TABLE 13 North America 2’FL Market, 2022 - 2033, USD Million
TABLE 14 North America 3’FL Market, 2022 - 2033, USD Million
TABLE 15 North America 3’SL Market, 2022 - 2033, USD Million
TABLE 16 North America 6’SL Market, 2022 - 2033, USD Million
TABLE 17 North America DFL Market, 2022 - 2033, USD Million
TABLE 18 North America LNnT Market, 2022 - 2033, USD Million
TABLE 19 North America LNT Market, 2022 - 2033, USD Million
TABLE 20 Canada Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
TABLE 21 Methodology for the research
TABLE 22 Key Factors Impacting Market
TABLE 23 Market Consolidation
TABLE 24 Key Customer Criteria
TABLE 25 Product Life Cycle
TABLE 26 Canada Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
TABLE 27 Canada Dietary Supplements Market, 2022 - 2033, USD Million
TABLE 28 Canada Food & Beverages Market, 2022 - 2033, USD Million
TABLE 29 Canada Infant Formula Market, 2022 - 2033, USD Million
TABLE 30 Canada Pharmaceuticals Market, 2022 - 2033, USD Million
TABLE 31 Canada Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
TABLE 32 Canada 2’FL Market, 2022 - 2033, USD Million
TABLE 33 Canada 3’FL Market, 2022 - 2033, USD Million
TABLE 34 Canada 3’SL Market, 2022 - 2033, USD Million
TABLE 35 Canada 6’SL Market, 2022 - 2033, USD Million
TABLE 36 Canada DFL Market, 2022 - 2033, USD Million
TABLE 37 Canada LNnT Market, 2022 - 2033, USD Million
TABLE 38 Canada LNT Market, 2022 - 2033, USD Million
TABLE 39 Mexico Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
TABLE 40 Methodology for the research
TABLE 41 Key Factors Impacting Market
TABLE 42 Market Consolidation
TABLE 43 Key Customer Criteria
TABLE 44 Product Life Cycle
TABLE 45 Mexico Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
TABLE 46 Mexico Dietary Supplements Market, 2022 - 2033, USD Million
TABLE 47 Mexico Food & Beverages Market, 2022 - 2033, USD Million
TABLE 48 Mexico Infant Formula Market, 2022 - 2033, USD Million
TABLE 49 Mexico Pharmaceuticals Market, 2022 - 2033, USD Million
TABLE 50 Mexico Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
TABLE 51 Mexico 2’FL Market, 2022 - 2033, USD Million
TABLE 52 Mexico 3’FL Market, 2022 - 2033, USD Million
TABLE 53 Mexico 3’SL Market, 2022 - 2033, USD Million
TABLE 54 Mexico 6’SL Market, 2022 - 2033, USD Million
TABLE 55 Mexico DFL Market, 2022 - 2033, USD Million
TABLE 56 Mexico LNnT Market, 2022 - 2033, USD Million
TABLE 57 Mexico LNT Market, 2022 - 2033, USD Million
TABLE 58 United States Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
TABLE 59 Methodology for the research
TABLE 60 Key Factors Impacting Market
TABLE 61 Market Consolidation
TABLE 62 Key Customer Criteria
TABLE 63 Product Life Cycle
TABLE 64 United States Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
TABLE 65 United States Dietary Supplements Market, 2022 - 2033, USD Million
TABLE 66 United States Food & Beverages Market, 2022 - 2033, USD Million
TABLE 67 United States Infant Formula Market, 2022 - 2033, USD Million
TABLE 68 United States Pharmaceuticals Market, 2022 - 2033, USD Million
TABLE 69 United States Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
TABLE 70 United States 2’FL Market, 2022 - 2033, USD Million
TABLE 71 United States 3’FL Market, 2022 - 2033, USD Million
TABLE 72 United States 3’SL Market, 2022 - 2033, USD Million
TABLE 73 United States 6’SL Market, 2022 - 2033, USD Million
TABLE 74 United States DFL Market, 2022 - 2033, USD Million
TABLE 75 United States LNnT Market, 2022 - 2033, USD Million
TABLE 76 United States LNT Market, 2022 - 2033, USD Million
TABLE 77 Rest of North America Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
TABLE 78 Methodology for the research
TABLE 79 Key Factors Impacting Market
TABLE 80 Market Consolidation
TABLE 81 Key Customer Criteria
TABLE 82 Product Life Cycle
TABLE 83 Rest of North America Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
TABLE 84 Rest of North America Dietary Supplements Market, 2022 - 2033, USD Million
TABLE 85 Rest of North America Food & Beverages Market, 2022 - 2033, USD Million
TABLE 86 Rest of North America Infant Formula Market, 2022 - 2033, USD Million
TABLE 87 Rest of North America Pharmaceuticals Market, 2022 - 2033, USD Million
TABLE 88 Rest of North America Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
TABLE 89 Rest of North America 2’FL Market, 2022 - 2033, USD Million
TABLE 90 Rest of North America 3’FL Market, 2022 - 2033, USD Million
TABLE 91 Rest of North America 3’SL Market, 2022 - 2033, USD Million
TABLE 92 Rest of North America 6’SL Market, 2022 - 2033, USD Million
TABLE 93 Rest of North America DFL Market, 2022 - 2033, USD Million
TABLE 94 Rest of North America LNnT Market, 2022 - 2033, USD Million
TABLE 95 Rest of North America LNT Market, 2022 - 2033, USD Million


List of Figures
FIG 1 Methodology for the research
FIG 2 Key Factors Impacting Market
FIG 3 Market Consolidation
FIG 4 Key Customer Criteria
FIG 5 Product Life Cycle
FIG 6 North America Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
FIG 7 North America Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
FIG 8 North America Dietary Supplements Market, 2022 - 2033, USD Million
FIG 9 North America Food & Beverages Market, 2022 - 2033, USD Million
FIG 10 North America Infant Formula Market, 2022 - 2033, USD Million
FIG 11 North America Pharmaceuticals Market, 2022 - 2033, USD Million
FIG 12 North America Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
FIG 13 North America 2’FL Market, 2022 - 2033, USD Million
FIG 14 North America 3’FL Market, 2022 - 2033, USD Million
FIG 15 North America 3’SL Market, 2022 - 2033, USD Million
FIG 16 North America 6’SL Market, 2022 - 2033, USD Million
FIG 17 North America DFL Market, 2022 - 2033, USD Million
FIG 18 North America LNnT Market, 2022 - 2033, USD Million
FIG 19 North America LNT Market, 2022 - 2033, USD Million
FIG 20 Canada Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
FIG 21 Canada Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
FIG 22 Canada Dietary Supplements Market, 2022 - 2033, USD Million
FIG 23 Canada Food & Beverages Market, 2022 - 2033, USD Million
FIG 24 Canada Infant Formula Market, 2022 - 2033, USD Million
FIG 25 Canada Pharmaceuticals Market, 2022 - 2033, USD Million
FIG 26 Canada Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
FIG 27 Canada 2’FL Market, 2022 - 2033, USD Million
FIG 28 Canada 3’FL Market, 2022 - 2033, USD Million
FIG 29 Canada 3’SL Market, 2022 - 2033, USD Million
FIG 30 Canada 6’SL Market, 2022 - 2033, USD Million
FIG 31 Canada DFL Market, 2022 - 2033, USD Million
FIG 32 Canada LNnT Market, 2022 - 2033, USD Million
FIG 33 Canada LNT Market, 2022 - 2033, USD Million
FIG 34 Mexico Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
FIG 35 Mexico Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
FIG 36 Mexico Dietary Supplements Market, 2022 - 2033, USD Million
FIG 37 Mexico Food & Beverages Market, 2022 - 2033, USD Million
FIG 38 Mexico Infant Formula Market, 2022 - 2033, USD Million
FIG 39 Mexico Pharmaceuticals Market, 2022 - 2033, USD Million
FIG 40 Mexico Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
FIG 41 Mexico 2’FL Market, 2022 - 2033, USD Million
FIG 42 Mexico 3’FL Market, 2022 - 2033, USD Million
FIG 43 Mexico 3’SL Market, 2022 - 2033, USD Million
FIG 44 Mexico 6’SL Market, 2022 - 2033, USD Million
FIG 45 Mexico DFL Market, 2022 - 2033, USD Million
FIG 46 Mexico LNnT Market, 2022 - 2033, USD Million
FIG 47 Mexico LNT Market, 2022 - 2033, USD Million
FIG 48 United States Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
FIG 49 United States Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
FIG 50 United States Dietary Supplements Market, 2022 - 2033, USD Million
FIG 51 United States Food & Beverages Market, 2022 - 2033, USD Million
FIG 52 United States Infant Formula Market, 2022 - 2033, USD Million
FIG 53 United States Pharmaceuticals Market, 2022 - 2033, USD Million
FIG 54 United States Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
FIG 55 United States 2’FL Market, 2022 - 2033, USD Million
FIG 56 United States 3’FL Market, 2022 - 2033, USD Million
FIG 57 United States 3’SL Market, 2022 - 2033, USD Million
FIG 58 United States 6’SL Market, 2022 - 2033, USD Million
FIG 59 United States DFL Market, 2022 - 2033, USD Million
FIG 60 United States LNnT Market, 2022 - 2033, USD Million
FIG 61 United States LNT Market, 2022 - 2033, USD Million
FIG 62 Rest of North America Human Milk Oligosaccharides Market Market, 2022 - 2033, USD Million
FIG 63 Rest of North America Human Milk Oligosaccharides Market Market by Application, 2022 - 2033, USD Million
FIG 64 Rest of North America Dietary Supplements Market, 2022 - 2033, USD Million
FIG 65 Rest of North America Food & Beverages Market, 2022 - 2033, USD Million
FIG 66 Rest of North America Infant Formula Market, 2022 - 2033, USD Million
FIG 67 Rest of North America Pharmaceuticals Market, 2022 - 2033, USD Million
FIG 68 Rest of North America Human Milk Oligosaccharides Market Market by Type, 2022 - 2033, USD Million
FIG 69 Rest of North America 2’FL Market, 2022 - 2033, USD Million
FIG 70 Rest of North America 3’FL Market, 2022 - 2033, USD Million
FIG 71 Rest of North America 3’SL Market, 2022 - 2033, USD Million
FIG 72 Rest of North America 6’SL Market, 2022 - 2033, USD Million
FIG 73 Rest of North America DFL Market, 2022 - 2033, USD Million
FIG 74 Rest of North America LNnT Market, 2022 - 2033, USD Million
FIG 75 Rest of North America LNT Market, 2022 - 2033, USD Million